The trademark application NEUMORA was filed by Neumora Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 12, 2022, and it was registered by office on July 20, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders.
The mark was filed in class 42 with following description of goods:
Research and development of pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders
Analyzing genetic, genomic, biological and clinical data for scientific research purposes
Analyzing genetic, genomic, biological and clinical data for the research and development pharmaceuticals for treating neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders via targeted drug therapies.